Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.425p 0.42p 0.45p - - - 1,471,362 09:00:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 0.1 -0.5 -0.0 - 7.40

Provexis (PXS) Latest News

More Provexis News
Provexis Takeover Rumours

Provexis (PXS) Share Charts

1 Year Provexis Chart

1 Year Provexis Chart

1 Month Provexis Chart

1 Month Provexis Chart

Intraday Provexis Chart

Intraday Provexis Chart

Provexis (PXS) Discussions and Chat

Provexis (PXS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:09:010.44410,0001,789.65O
12:02:410.4412,00052.20O
10:42:060.43208,871906.50O
09:00:230.45840,4913,778.01O
View all Provexis trades in real-time

Provexis (PXS) Top Chat Posts

DateSubject
26/9/2016
09:20
Provexis Daily Update: Provexis Plc is listed in the Food Producers sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.43p.
Provexis Plc has a 4 week average price of 0.42p and a 12 week average price of 0.36p.
The 1 year high share price is 0.50p while the 1 year low share price is currently 0p.
There are currently 1,740,401,507 shares in issue and the average daily traded volume is 1,268,942 shares. The market capitalisation of Provexis Plc is £7,396,706.40.
15/8/2016
01:00
wheelds: We have had a terrible last 5 years but all being well we are hopefully now on the mend which will be highlighted come this September..IMHO 07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up 07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up 07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up 07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up July low share price 0.26p today 0.36p = 40% rise in one month. Preliminary Results September 2016 Annual General Meeting 30 September 2016
14/8/2016
03:08
wheelds: It looks like the market expectations for Provexis has improved, and the rise in the share price seems to confirm this factor since the last fund raising to give us enough cash to keep going as revenues increase:- "In June 2015 the Company confirmed it had agreed significantly enhanced financial terms for its Alliance Agreement with DSM for Fruitflow®."
17/5/2016
18:03
wheelds: A good bid price of 0.32p when share price is 0.335p shows the market makers are confident in rise today.IMHO Lets hope this is the beginning of an upward trend
13/4/2016
22:01
wheelds: 59 products now with added Fruitflow and I remember Moon saying a few years back that all we needed was around 15 to 20 products before we would be getting into a healthy profit. However since then we have been updating patents around the world and with DSM being our global partner supplying 59 products around the world is obviously very costly but last year they did say they were now getting production costs under control. So, all being well, we should start to see an increase in revenues from our 59 products this year.IMHO And the last product (healthy blood pressure" should be a winner.IMHO and when the results come out on improving memory again the world will be very interested in our Fruitflow products and revenues will increase.IMHO And keeping my fingers crossed, the share price just might go back above 1p and up and up again over the years.IMHO https/www.nia.nih.gov/alzheimers/clinical-trials/effects-fruitflow-ii-and-resveratrol-memory-fitness-and-cerebral-blood 59/ GNC Healthy Blood Pressure March 2016 58/ Nobilin Cardioflow feb 2016 57/ CircuFlo feb 2016 56/Elite meal replacement soup Jan 2016 55/ Winfrey Su Jan 2016 54/Ven ReleVit Jan 2016 53/Cardio Veda jan 2016 52/ Koromed Nov 2015 51/ AS-Formula, 60 Capsules Oct 2015 50/Vascumax oct 2015 49/Performance Pump - 30 Servings Oct2015 48/ MK-7 Artery Circulation™ sept 2015 FF2 47/Pro Performance AMP Amplified Maxertion N.O. Sept 2015 46/Vitacell ® Cardio FF2 Sept 2015 45/ Elixir Vitality FF2 August 2015 44/ Thromballur Forte FF2 July 2015 43/GNC Mega Men® Extreme Athlete Vitapak® FF2 july2015 42/ GranaMed FF2 June 2015 41/HYDRINX™ FF2 May 2015 40/ Venoflow FF2 May 2015 39/ Endure Prime April 2015 38/ Tromboserin FF2 Feb 2015 37/ Artiflow FF2 + Omega3 Jan 2015 36/ Thrombo 3 Protect FF2 + omega3 Jan2015 35/Syntrival FF2 nov 2104 34/ Vida Maxx ff2 nov 2014 33/RIPPD Performance Preworkout oct ff2 2014 32/ Carbonated green juice june 2014 31, wasaka ff2 june 2014 30/Blutfluss in balance ff2 june 2014 29/ Prontoflow ff2 may 2014 in development not on general sale 28/ Flyfitflow feb 2014 27 /Song Li through -F® feb 2014 ???* 26/Sperm vitality ff2 feb 2014 25/ Cardio-in-form thromboflux ff2 feb 2014 24 Zaax ff2jan 2014 23Performance prime ff2 jan 2014 22/Dr. Ehrlich's veins ff2 capsules jan 2014 21 Fertilichron Dec? ff22013 20//Dr. Jacobs - Mediterranean Pomegranate Elixir. Poland Sept 2013 20/a and a slightly different product- Germany 20/b Switzerland 20/c France 19/ Freestream August 2013 18/ Liqui Blut FF1 August 2013 17/ Thrombophenol FF2 august 2013 16/ Thromboflow FF2 capsule June 2013 15/ Thrombalance May 2013 14/ Tomaflow FF1 May 2013 13/Circulease FF2 capsules May 2013 12/ OptiFlow FF2 capsules. May 2013 11//L&A Juice March 2013? 10/Red Beet Vinitrox, sports drink January 2013 XX/ SiS REGO + FRUITFLOW GEL January 2013-2015 DISCONTINUED GRRR MOON 9/ OptiFlow November 2012 8/ Wellness Shot Oct 2012 7/Langers tomato juice + sept 2012 6/ Thromboflow Sept 2012 5/Flyhidrate New Zealand. April 2012 bankrupt feb 2016 re-launched April 2016 4/Biocol Flow ampules Nov 2011xxxxx fire at factory disrupts production 3/ Bloodfruit syrup USA Sept 2011 2/ SWANSONS capsules August 2011 1/ SIRCO fruit juice UK April 2010
08/1/2016
17:31
wheelds: If this study can be shown to improve memory loss then the potential for our 50 plus fruitflow products can only be positive and you never know the share price might rise again based on market expectations that DSM, our partner who is spending millions on promoting Fruitflow products around the world, is going to buy us out. IMHO I would guess PXS directors are confident that the results will be positive, hence that's why they just bought a few more million shares. IMHO hxxp://www.neurogrow.com/our-clinical-trial-memosyn-neurology-institute.html that's http "Memosyn Fruitflow and Resveratrol Study" "The data collection for this study is now completed and we are in the process of analyzing our results." ​For more information, please call 703.462.9296. "In this study, we are planning to evaluate the effects of two natural supplements on cognitive function and blood flow to the brain in persons with memory complaints. Fruitflow is a tomato extract component which has been shown to modify platelet activity in the vascular system and may have beneficial effects on systemic blood flow. This effect of Fruitflow is similar to aspirin which has antiplatelet activity and is used for a long time for secondary prevention of cardiovascular and cerebrovascular events in patients. In this study, our goal is to find out whether fruitflow has any beneficial effects on blood flow to the brain and thereby improving memory problems. We also evaluate effects of another natural supplement, Resveratrol, on cognitive functions, blood flow to the brain and fitness alone or in combination with Fruitflow. Resveratrol is a natural compound found in the skin of red grapes and also in wine."
05/6/2015
00:08
wheelds: I would like to put a bid in for two million shares at 0.35p. and when the S.P in say a years time is at 1p I will sell a million and keep the rest for say another 2 years and then sell another million at 3p; and then live happy ever after until share price reaches 10p again or DSM buys us out for 5p in say 3 years. Nobody knows really what the share price will be in say 2 years plus but I am confident it will be higher then 0.35p.IMHO
04/6/2015
19:30
wheelds: Last time Provexis had a fund raising event involving share holders when the share price was at around 7p; according to a percentage of how many share you hold you could put in a bid for around 3.5p; which I did and once confirmed sold at 6p as the share price was obviously on its way down and down, but this time the future is bright, very bright, IMHO and I will take up my whole percentage offer and hold this time unless the weather changes. Today's news is in general good news.IMHO However, to cover my investment, I sold one million today at 0.52p which I had just bought last week for 0.47p, giving me £5200,00p to invest later if we get a good offer on the bid.com fund raising event. Good luck which ever way you think best. If the bid price now keeps going up and up then I will sell some more but I intend to keep a good percentage for re-investing in this marvelous health product.
30/3/2013
22:01
wheelds: 2005 ASOS fell to 50p due to fire in warehouse. - today at £33,33.50p 2003 Arm holdings fell to 40p due to cancelling of orders, - today at £9,18.50p So whats the link? - both companies leading in today's customer needs. ASOS, an online catalogue company; Arm Holdings, supplying the parts needed for Mobile phones etc. Hence, what do we have today that is in global demand??? And what share price has fallen dramatically due to short term commercial difficulties.??? while global consumer need and even government concerns on health are growing.??? In my opinion, as long as the partnership between Provexis and DSM works out, PXS share price over the next 10 years will keep on rising year on year; unless PXS is bought out. IMHO
26/11/2012
00:08
wheelds: theuniversal:- Lets see what happens next week and upto Dec.results, I think this week was the last chance to buy in around the 1.5p mark. I am expecting, based on Provexis meeting market expectations, by this time next Friday the share price to be back to around 2p as we get closer to Dec.Results, and Friday's last minute share price jump was a good indicator of things to come. IMHO. In my honest opinion, as long as we all live past Dec.22nd, (end of the world theory) PXS share price can only get better year on year for the next 5 years as more and more people around the world will want access to the wonder Fruitflow product, (not a drug as the chinese pointed out in their article) and this is exactly what DSM is preparing for with manufacturing basis set up around the globe. And of course SIS products will also continue to be in big demand as athletes around the world strive to do better. DSM and Provexis partnership is working:- http://www.youtube.com/watch?v=vr1_FE7GTPo&feature=related
06/1/2012
13:13
gkb: Brilliant post by Scaramouche over on iii today. He / she mentions a major concern; the lack of clear strategy and exposure by the PXS BoD re. FF. The answer is clear. SM has moved on. OKennedy and Heeney have taken over the reins re. WSTC science and commercialisation which is fine BUT the BoD should regard news about FF as relevant to the PXS share price and as such it should NOT be left to DSM or 3rd parties to provide info. as and when. Essentially the share price (us really) is paying the price for this lack of focus. In the long run it won't matter providing there's nothing untoward going on in the background, but here's my worry. What if SM has moved on and PXS will sell on FF rights for a pittance to DSM? If that happened it wouldn't matter that DSM's venture capital arm takes a hit on the share price and they wouldn't be bothered about the HNWIs. Once taken on board, PXS as DSM's R&D branch would be a foregone conclusion. SM then sits pretty, R&D is OK and the current shareholders are screwed. I realise that even posting like this is likely to be negative for the share price but if we make enough noise, perhaps we could alter the outcome. To me this explains the distinct lack of push by PXS, the lack of exposure, the lack of updates and the tendency for the Bod to disregard the SP, seemingly at all costs (not to mention the appalling scientific direction over the last couple of years). Scaramouche's concerns are appropriate IMO and the above may explain why. If I'm wrong, we've got an unfocussed, incompetent BoD run by an ego who treats PI's as cash cows. If I'm right, we've got a fight on our hands and it is essential that we organise a shareholders' action group. It won't be easy considering the egos (mine included) but if we're serious about our investment, it's the only way. Come on Mayven. Can it be done?
Provexis share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20160926 13:57:57